Description
Hemovigilance is an important activity in the licensed operation of blood transfusion laboratories. Serologic testing doesn’t stand alone, but is linked to a therapeutic dispensary with consequences. This session addresses how internal (and overall blood system) safety is met in the context of three layers: pre-release activities (limiting inappropriate use and assuring compatibility), relevant exercises around disturbances associated with blood products (using structured approaches to recognition and case formulation), and reporting duties after the fact (relating to what must be tracked, who it must be shared with, and why).
Objectives
1. Relate the role of the transfusion laboratory in reaction avoidance, relating to resource stewardship and compatibility testing.
2. Restate the policy & procedure structures enabling bedside reaction identification, reporting, appropriate testing, and management.
3. Select the laboratory’s situational reporting mandates (internally to the hospital transfusion committee, and externally to manufacturers & regulators)
Target Audience
Faculty
Residents
Medical Students
CanMEDS Roles
Medical Expert (the integrating role)
Communicator
Collaborator
Health Advocate
Professional
Dr. Christine Cserti-Gazdewich